Bispecific IgG switch off SARS-CoV-2 escap...A bispecific antibody designed by a Swiss-Czech research team suppressed viral escape of SARS-CoV-2 variants in animals. more ➔
Step Pharma SAS raises €35m in Series BKurma Partners-founded Step Pharma has baged €35m in a Series B financing to advance its blood cancer lead STP938. more ➔
Europe needs a strategyThe threat caused by the SARS-CoV-2 virus is a global one. Therefore, we have to address the coronavirus pandemic globally, but at least on a European scale. To achieve this, we need not only a vaccination … more ➔
AZD1222 claims 79% effecacy in pivotal US... Following assemingly good results in a Phase III study AstraZeneca goes for Emergency Use Approval in the US. more ➔
EMA recommends to continue AZD1222 vaccina...On Tuesday, Emer Cooke had already hinted at it. Now the EMA’s PRAC committee confirmed: the benefits of AZ1222 by far outweigh the risks of the COVID-19 vaccine. more ➔
Novel COVID antibody enters clinical testi...German CORAT Therapeutics GmbH got the greenlight for Phase Ib/II testing of COR-101, an antibody that reduced virus load in the lung by more than 99 % within three days. more ➔
Don’t bet only on vaccines!First emergency approvals of vaccines and antibody drugs in less than a year are great achievements of modern biotechnology in our battle against the COVID-19 pandemic, but we still have no efficient … more ➔
B.1.1.7 variant associated with higher mor...The B.1.1.7 variant of SARS-CoV-2, which was first identified in the UK, may be associated with an increased risk of death, a Nature study suggests. more ➔
Roche in take-over deal with GenMark Diagn...Roche to acquire GenMark Diagnostics, Inc., to access platform to test for broad range of pathogens with one patient sample. more ➔
Media hype on Denmark’s decision to...While media reports suggest AstraZeneca’s COVID-19 jab might have caused blot clots, the EMA didn’t confirm a causal relationship. more ➔
